Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure (Q57259661)
Jump to navigation
Jump to search
scientific article published on 01 November 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure |
scientific article published on 01 November 2000 |
Statements
Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators (English)
Zannad F
Perez A
1 November 2000